参考文献 1 温泽锋, 姜平, 童鑫康. 血脑屏障与血管性痴呆的研究进展[J]. 国外医学(老年医学分册), 2007, 28:211-216. 2 胡潇, 余涓. 星形胶质细胞在血脑屏障与神经元损伤中的作用[J]. 神经解剖学杂志, 2012, 28:330-334. 3 景玉红, 宋焱峰, 王子仁. 血管性痴呆大鼠星形胶质细胞增生与TNF-α的表达[J]. 中华神经医学杂志, 2004, 3:418-421. 4 梁国聪, 石胜良, 毕桂南, 等. β淀粉样蛋白和tau蛋白在血管性痴呆发病机制中的作用[J]. 广西医科大学学报, 2011, 28:661-664. 5 承欧梅, 钟世江, 宴勇, 等. 脑卒中和血管性痴呆β淀粉样蛋白测定及临床意义[J]. 重庆医学, 2004, 33:555-556. 6 Liu JP, Chang LR, Francesco R, et al. Amyloid-β induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors[J]. J Alzheimers Dis, 2010, 22:541-556. 7 邵福源, 黄流清, 薛红, 等. 血管性痴呆研究[J]. 中国临床神经科学, 2001, 9:92-95. 8 Sudduth TL, Weekman EM, Brothers HM, et al. β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice[J]. Alzheimers Res Ther, 2014, 6:32-32. 9 周爱红, 王荫华. 阿尔茨海默病与血管性危险因素[J]. 中华老年心血管病杂志, 2005, 7:65-67.10 赵万红, 罗超. 阿尔茨海默病与脑缺血的相互作用[J]. 中国老年学杂志, 2013, 33:5206-5209.11 蔺心敬, 李吕力, 杨德刚, 等. 血管性痴呆大鼠海马神经元凋亡和蛋白表达实验研究[J]. 中国现代医学杂志, 2007, 17:2326-2329.12 Li P, Nijihawan D, Budihardjo I, et al. Cytochrome C dATP-dependent formation of Apaf-1/easpase-9 complex initiates an apoptoic protease cascade[J]. Cell, 1997, 91:479-489.13 Budihardjo I, Oliver H, Lutter M, et al. Biochemical of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis[J]. Annu Rev Cell Del Bio, 1999, 15:269-290.14 Ashkenazi A, Dixit VM. Death receptors:signaling and modulation[J]. Science, 1998, 281:1305-1308.15 Tiraboschi P, Hansen LA, Alford M, et al. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease[J]. Neurology, 2000, 55:1278-1283.16 Scheff SW, Price DA, Schmitt FA, et al. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment[J]. Neurobiol Aging, 2006, 27:1372-1384.17 Götz J, Ittner LM, Schonrock N, et al. An update on the toxicity of Abeta in Alzheimer's Disease[J]. Neuropsychiatr Dis Treat, 2008, 4:1033-1042.18 王菲. 血管性痴呆的分子机制及治疗学研究进展[J]. 中国神经精神疾病杂志, 2014, 40:317-320.19 Allaman I, Bélanger M, Magistretti PJ. Astrocyte-neuron metabolic relationships:for better and for worse[J]. Trends Neurosci, 2011, 34:76-87.20 Takuma K, Baba A, Matsuda T. Astrocyte apoptosis:implications for neuroprotection[J]. Prog Neurobiol, 2004, 72:111-127. 21 宋一志, 高香红, 常丽荣, 等. 星形胶质细胞对β-淀粉样蛋白诱导神经元凋亡的影响[J]. 神经解剖学杂志, 2013, 29:108-114.22 Nielsen HM, Mulder SD, Beliën JA, et al. Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins[J]. Glia, 2010, 58:1235-1246. 23 Dorfman VB, Pasquini L, Riudavets M, et al. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease[J]. Neurobiol Aging, 2010, 31:1743-1757. 24 Garwood CJ, Pooler AM, Atherton J, et al. Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture[J]. Cell Death Dis, 2011, 167:1-9.25 Qin H, Benveniste EN. ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro[J]. Methods Mol Biol, 2012, 814:235-249. 26 Reddy PH, Manczak M, Mao P, et al. Amyloid-beta and mitochondria in aging and Alzheimer's disease:implications for synaptic damage and cognitive decline[J]. J Alzheimers Dis, 2010, 20:499-512.27 Lustbader JW, Cirilli M, Lin C, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease[J]. Science, 2004, 304:448-452. |